News · Immunology
996 stories
Oct 9, 26Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionary
Oct 9, 26‘We’re making a lot of progress’: How Nobel-winning optogenetics is being harnessed by biotechs
Oct 9, 26Lilly-backed TRex rakes in $117M IPO, while hypertension biotech Retension reveals $45M listing
Oct 8, 26STAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease
Oct 8, 26STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
Oct 8, 26Ono pays $80M for regional rights to trio of Biohaven IgG degraders, including phase 3 Grave’s asset